Medicare 2028 Drug Price Cuts: Cancer, Arthritis, and HIV Medications Affected

:## Analysis of the Article

1. Core ⁢Topic & Intended audience:

The core topic of the article is the announcement of the‍ next 15 drugs selected for ⁣Medicare⁣ price negotiations under ⁤the Inflation reduction Act (IRA). It details which drugs are included, ‍the⁤ potential impact on pharmaceutical companies, and the ⁣industry’s response. ⁤

The intended audience is professionals ⁢in⁤ the healthcare industry – specifically those involved in‍ pharmaceuticals, healthcare⁢ policy, healthcare finance, and possibly those working within Medicare/CMS. It also⁤ targets individuals interested in healthcare ⁤news and the impact of the IRA on drug pricing. The level of detail and terminology suggests it’s not ⁢ aimed at a general consumer audience.

2. Optimal Keywords:

* ‍ Primary Topic: Medicare ⁤Drug Price Negotiation
* Primary Keyword: Medicare Drug Pricing
*⁤ Secondary Keywords:

* ⁣ Inflation Reduction Act (IRA)
⁣ * CMS (Centers for Medicare ⁢& Medicaid Services)
* Drug Pricing
* Pharmaceutical Industry
* ‍ Trulicity
* Biktarvy
* Kisqali
* Verzenio
⁤ * Medicare Part B
* ⁣ Prescription Drug Costs
* Healthcare Policy
*‍ ‍Pharmaceutical Regulation
* Drug ⁢Negotiation
* Gilead ⁤Sciences
⁢ * Eli‍ Lilly
* ‍ Cancer Drugs
* HIV Treatment
* Rheumatoid Arthritis Drugs
⁤ * Botox
* Keytruda
⁣* Opdivo
‍ * One Big Gorgeous Bill Act
‍* PhRMA (Pharmaceutical⁣ Research ⁣and Manufacturers of America)
* Healthcare costs
⁢ * prescription Drugs
* ⁣ Medication Costs
* Small Molecule Drugs
* biologic Medications